UCB SA UCBJF
Set alert
317.34 USD +0.93 +0.29%
At close · Oct 30
317.00 Day range 317.00
219.60 52-week range 345.39
- YTD
- +8.09%
- 1 year
- +19.32%
- Open
- 317.00
- Prev close
- 316.41
- Mkt cap
- 60.50B
- Vol
- 3
- Avg vol
- 395
- EPS
- 13.21
- P/E
- 24.02
More statistics
- Low
- 317.00
- High
- 317.00
- Earnings
- Feb 25, 2027
News
1 week ago benzinga.com
What's Going On with MoonLake Immunotherapeutics Stock on Thursday?
MoonLake stock rallies after AbbVie HS data misses competitor benchmarks, reinforcing sonelokimab's competitive positioning ahead of 2027 launch plans.
9 months ago benzinga.com
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.
9 months ago benzinga.com
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.
11 months ago benzinga.com
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline
Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.